Mirsaid M. Mirrakhimov was born in 27 March 1927 at Frunze, Soviet Union (currently Bishkek, Kyrgyzstan), into a family of well-known local musician and director of National Philharmonics. After graduating school with honors, he decided to study medicine, despite a talent in music and his father’s insistence to follow his path. He was the first ever member of his family to pursue medicine. After passing entrance examinations, he became a student of the Kyrgyz State Medical Institute (KSMI, currently Kyrgyz State Medical Academy), from which he graduated with distinction. Despite an invitation from a famous local surgeon to enter surgical residency, Mirsaid M. Mirrakhimov pursued the internal medicine pathway, in which he had a keen interest. He finished residency in 1952, and was recruited as assistant professor of medicine at the Department of Internal Medicine, and started his Ph.D. work. In 1966, he became a full professor and was elected as the chief of Internal Medicine Department of the KSMI. Following his initiative and efforts, the National Center of Cardiology and Internal Medicine (NCCIM) was founded in 1977 at Frunze—the first such center in the whole Central Asian region. Prof. Mirrakhimov served as director of NCCIM from its foundation until 2007. As a part of recognition of his outstanding contribution for medical science, he was elected as a full member of the Academy of Medical Sciences of the Soviet Union in 1988. In 2001 NCCIM was named after Prof. Mirrakhimov by the decision of the president of the Kyrgyz Republic. As a scientist, he proved to be an extraordinarily gifted and creative investigator. He developed a number of novel diagnostic and therapeutic methods for general and environmental cardiology, particularly in the field of the high altitude physiology, adaptation of subjects to high altitude, and high-altitude pulmonary hypertension (HAPH). Mirsaid Mirrakhimov and colleagues showed that people residing at high altitude have a lower chemoreceptor threshold for PaCO2 [1]. Another important finding by his research group was that patients with HAPH have lower density of betaadrenoreceptors compared to healthy people [2]. Another study entitled “New approaches to noninvasive assessment of pulmonary artery pressure,” published in the Clinical Cardiology in 1992, became a classic and pioneering A. E. Mirrakhimov (*) Kyrgyz State Medical Academy, Akhunbaev Street 92, Bishkek 720020, Kyrgyzstan e-mail: amirrakhimov1@gmail.com
Read full abstract